🇺🇸 FDA
Patent

US 9277748

Agonist/antagonist compositions and methods of use

granted A61KA61K31/165A61K31/18

Quick answer

US patent 9277748 (Agonist/antagonist compositions and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/165, A61K31/18, A61K31/357, A61K31/4468